Ancora Advisors, LLC Esperion Therapeutics, Inc. Transaction History

Ancora Advisors, LLC

  • $4.06 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020
SELL
$30.04 - $51.31 $214,035 - $365,583
-7,125 Closed
0 $0
Q1 2020

May 14, 2020
BUY
$27.44 - $73.84 $133,770 - $359,970
4,875 Added 216.67%
7,125 $225,000
Q4 2019

Feb 14, 2020
BUY
$35.4 - $59.82 $79,650 - $134,595
2,250 New
2,250 $134,000

Others Institutions Holding ESPR

# of Institutions
210
Shares Held
129M
Call Options Held
1.67M
Put Options Held
930K
View Full List

About Esperion Therapeutics, Inc.

ESPR Quotes by TradingView
  • Ticker ESPR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,551,600
  • Market Cap $120M
  • Description
  • Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...
More about ESPR
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email